金城医药
(300233)
| 流通市值：49.25亿 | | | 总市值：50.79亿 |
| 流通股本：3.72亿 | | | 总股本：3.84亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,447,244,579.85 | 750,421,565.86 | 2,736,927,222.73 | 1,932,025,566.29 |
| 营业总成本 | 1,317,835,512.27 | 675,692,157.8 | 2,629,657,047.77 | 1,891,362,105.7 |
| 其他经营收益 | | | | |
| 营业利润 | 174,780,775.81 | 77,000,342.37 | 84,216,512.3 | 52,885,072.12 |
| 利润总额 | 173,379,656.26 | 76,156,474.19 | 78,021,221.17 | 50,577,835.11 |
| 净利润 | 141,492,562.53 | 59,010,239.34 | 42,273,760.23 | 33,598,077.72 |
| 每股收益 | | | | |
| 其他综合收益 | -750,000 | - | -1,702,679.15 | -33,584.91 |
| 综合收益总额 | 140,742,562.53 | 59,010,239.34 | 40,571,081.08 | 33,564,492.81 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,169,335,588.31 | 2,174,755,527.31 | 2,085,834,424.3 | 1,894,736,087.25 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,939,537,547.81 | 3,036,210,690.67 | 3,105,057,247.78 | 3,246,316,788.9 |
| 资产总计 | 5,108,873,136.12 | 5,210,966,217.98 | 5,190,891,672.08 | 5,141,052,876.15 |
| 流动负债: | | | | |
| 流动负债合计 | 1,136,711,125.72 | 1,255,118,104.92 | 1,222,088,936.38 | 1,084,641,538.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 162,529,891.47 | 171,530,952.07 | 244,836,970.3 | 339,002,696.18 |
| 负债合计 | 1,299,241,017.19 | 1,426,649,056.99 | 1,466,925,906.68 | 1,423,644,234.63 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,746,432,905.7 | 3,722,521,275.5 | 3,663,385,616.5 | 3,650,215,453.43 |
| 股东权益合计 | 3,809,632,118.93 | 3,784,317,160.99 | 3,723,965,765.4 | 3,717,408,641.52 |
| 负债和股东权益合计 | 5,108,873,136.12 | 5,210,966,217.98 | 5,190,891,672.08 | 5,141,052,876.15 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,169,316,627.71 | 594,193,338.68 | 2,422,456,259.82 | 1,771,631,144.06 |
| 经营活动现金流出小计 | 975,541,380.31 | 506,691,341.54 | 2,102,816,218.56 | 1,587,448,882.49 |
| 经营活动产生的现金流量净额 | 193,775,247.4 | 87,501,997.14 | 319,640,041.26 | 184,182,261.57 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,488,912,668.96 | 598,452,703.61 | 1,481,938,679.73 | 749,919,604.9 |
| 投资活动现金流出小计 | 1,405,545,945.52 | 690,213,567.01 | 1,637,894,545.29 | 887,302,639.62 |
| 投资活动产生的现金流量净额 | 83,366,723.44 | -91,760,863.4 | -155,955,865.56 | -137,383,034.72 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 94,000,000 | 60,000,000 | 137,975,000 | 137,975,000 |
| 筹资活动现金流出小计 | 199,395,053.95 | 105,051,169.53 | 436,674,073.28 | 432,966,504.58 |
| 筹资活动产生的现金流量净额 | -105,395,053.95 | -45,051,169.53 | -298,699,073.28 | -294,991,504.58 |
| 汇率变动对现金及现金等价物的影响 | -1,863,133.93 | -860,202.48 | 1,843,586.64 | 1,973,205.38 |
| 现金及现金等价物净增加额 | 169,883,782.96 | -50,170,238.27 | -133,171,310.94 | -246,219,072.35 |
| 期末现金及现金等价物余额 | 915,196,582.42 | 695,142,561.19 | 745,312,799.46 | 632,265,038.05 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 169,883,782.96 | - | -133,171,310.94 | - |